Flonase Sensimist Approval History
- FDA approved: Yes (First approved August 2nd, 2016)
- Brand name: Flonase Sensimist
- Generic name: fluticasone furoate
- Dosage form: Nasal Spray
- Company: GlaxoSmithKline Consumer Healthcare LP
- Treatment for: Allergic Rhinitis
Flonase Sensimist (fluticasone furoate) is an over-the-counter corticosteroid nasal spray indicated for the treatment of symptoms associated with seasonal and perennial allergies in adults and children ages 2 years and older.
Flonase Sensimist is administered via the nostrils once daily for 24-hour relief of both nose- and eye-related allergy symptoms such as itchy, watery eyes, nasal congestion, runny nose, itchy nose and sneezing.
Flonase Sensimist was previously available by prescription as Veramyst.
Development History and FDA Approval Process for Flonase Sensimist
|Aug 2, 2016||FDA Approves Flonase Sensimist Allergy Relief|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.